ArticleBone marrow transplantation2008

Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

G J Ruiz-Argüelles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.